Mylan Launches Generic AXERT Tablets - Quick Facts

(RTTNews) - Mylan N.V. (MYL) reported the U.S. launch of Almotriptan Tablets USP, 6.25 mg and 12.5 mg, the generic version of Janssen Pharmaceutical's AXER.

Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, used for the acute treatment of migraine attacks in adult patients with a history of migraine with or without aura.

In adolescents aged 12 to 17 years, it is indicated for the acute treatment of migraine headache pain in patients with a history of migraine attacks with or without aura usually lasting 4 hours or more when untreated.

lmotriptan Tablets USP, 6.25 mg and 12.5 mg, had U.S. sales of $29.2 million for the 12 months ending September 30, 2015, according to IMS Health.